Estrogen Receptor Beta rs1271572 Polymorphism and Invasive Ovarian Carcinoma Risk: Pooled Analysis within the Ovarian Cancer Association Consortium

• Galina Lurie ,

  * E-mail: GLurie@crch.hawaii.edu

  Affiliation Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America

  ⨯
• Lynne R. Wilkens,

  Affiliation Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America

  ⨯
• Pamela J. Thompson,

  Affiliation Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America

  ⨯
• Yurii B. Shvetsov,

  Affiliation Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America

  ⨯
• Rayna K. Matsuno,

  Affiliations Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Michael E. Carney,

  Affiliation Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, United States of America

  ⨯
• Rachel T. Palmieri,

  Affiliation Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Anna H. Wu,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Malcolm C. Pike,

  Affiliations Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Celeste L. Pearce,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Usha Menon,

  Affiliation Department of Gynecological Oncology, University College London EGA Institute for Women's Health, London, United Kingdom

  ⨯
• Aleksandra Gentry-Maharaj,

  Affiliation Department of Gynecological Oncology, University College London EGA Institute for Women's Health, London, United Kingdom

  ⨯
• Simon A. Gayther,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Susan J. Ramus,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America

  ⨯
• Alice S. Whittemore,

  Affiliation Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Valerie McGuire,

  Affiliation Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Weiva Sieh,

  Affiliation Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Paul D. P. Pharoah,

  Affiliation Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Honglin Song,

  Affiliation Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Jacek Gronwald,

  Affiliation Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Anna Jakubowska,

  Affiliation Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Cezary Cybulski,

  Affiliation Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Jan Lubinski,

  Affiliation Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Joellen M. Schildkraut,

  Affiliation Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Andrew Berchuck,

  Affiliation Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Susanne Krüger Kjær,

  Affiliations Department of Viruses, Hormones and Cancer, Danish Cancer Society, Institute of Cancer Epidemiology, Copenhagen, Denmark, Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Estrid Høgdall,

  Affiliation Department of Viruses, Hormones and Cancer, Danish Cancer Society, Institute of Cancer Epidemiology, Copenhagen, Denmark

  ⨯
• Peter A. Fasching,

  Affiliation Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States of America

  ⨯
• Matthias W. Beckmann,

  Affiliation Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Nürnberg, Germany

  ⨯
• Arif B. Ekici,

  Affiliation Institute of Human Genetics, Friedrich-Alexander University Erlangen-Nürnberg, Nürnberg, Germany

  ⨯
• Alexander Hein,

  Affiliation Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Nürnberg, Germany

  ⨯
• Georgia Chenevix-Trench,

  Affiliation Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Penelope M. Webb,

  Affiliation Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Jonathan Beesley,

  Affiliation Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• The Australian Ovarian Cancer Study and Australian Cancer Study Groups,

  Affiliation Queensland Institute of Medical Research, Brisbane, Australia and Peter MacCallum Cancer Study, Melbourne, Australia

  ⨯
• Marc T. Goodman,

  Affiliation Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America

  ⨯
•  [ ... ],
• The Ovarian Cancer Association Consortium
• [ view all ]
• [ view less ]